Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:58 PM
Ignite Modification Date:
2025-12-24 @ 4:58 PM
NCT ID:
NCT00003650
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Histologically and/or cytologically confirmed T cell or pre-B cell non-Hodgkin's lymphoma
* Lymphoblastic or peripheral T cell
* Stage I, II, III, or IV
* No anaplastic lymphoma, large cell lymphoma, or small noncleaved cell lymphoma
PATIENT CHARACTERISTICS:
Age:
* 18 and under
Performance status:
* Not specified
Life expectancy:
* Not specified
Hematopoietic:
* Not specified
Hepatic:
* Not specified
Renal:
* Not specified
Other:
* No prior malignancy
* No chronic medical or psychological condition
* No congenital immunodeficiency
* HIV and HTLV negative
* Not pregnant
PRIOR CONCURRENT THERAPY:
Biologic therapy:
* Not specified
Chemotherapy:
* No prior chemotherapy
Endocrine therapy:
* Prior corticosteroids allowed
Radiotherapy:
* Not specified
Surgery:
* No prior organ transplant
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
0 Years
Maximum Age:
18 Years
Study:
NCT00003650
Study Brief:
Protocol Section:
NCT00003650